Form4insider filings, from the source

SEC Form 3 · accession 0001104659-16-121886

Adverum Biotechnologies, Inc. · ADVM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
May 11, 2016
Accepted (ET)
May 18, 2016 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———6,660,981IThrough Versant Capital IV (Switzerland) GmbH
Common StockF2holding———2,176IThrough Versant Side Fund IV, L.P.
Common StockF3holding———340,735IThrough Versant Venture Capital IV, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses